CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 18:44 UTC

The Annexure

Desk› Healthcare› Krebs Biochemicals & Industries Ltd

Krebs Biochemicals & Industries Ltd

BSE 524518 KREBSBIO INE268B01013
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 61 trading days

8 filings · 3 material · busiest 2026-06-26 and 2026-08-06

What it files

Newspaper Publication1 Board Outcome1 Results1 Board Meeting1 Compliance Certificate1 Outcome1 Scheme of Arrangement1 Trading Window1

Filings

8 in the window

  1. 7 August 2026

    Newspaper Publication

    Newspaper Publication

    The Company has enclosed herewith copy of newpapers advertiesment of unaudited financial results for the quarter ended 30.06.2026

    Company Update / Newspaper Publication View filing →

  2. 6 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of BM

    Outcome of BM

    Board Meeting / Outcome of Board Meeting View filing →

  3. 6 August 2026

    Results

    Results

    Results for the quarter ended 30602026

    Result / Financial Results View filing →

  4. 28 July 2026

    Board Meeting

    Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 6Th Agust 2026

    Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2026 ,inter alia, to consider and approve Intimation ....

    Board Meeting / Board Meeting View filing →

  5. 2 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    The Company has enclosing herewith Certficate recived from RTA under Reg 74 (5) of DP Regulations, 2018 for the quarter ended 31.06.2026.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  6. 26 June 2026

    Outcome

    Board Meeting Outcome for Outcome Of Board Meeting

    Outcome of Board Meeting

    Others / Outcome without intimation View filing →

  7. 26 June 2026

    Scheme of Arrangement

    Scheme of Arrangement

    outcome of Baorad meeting

    Company Update / Scheme of Arrangement View filing →

  8. 22 June 2026

    Trading Window

    Closure of Trading Window

    The Company has enclosed herewith intimation for closure of trading window for the quareter ended 30.06.2026

    Insider Trading / SAST / Closure of Trading Window View filing →